Jeevan Scientific Technology Ltd is Rated Hold

Understanding the Current Rating

The 'Hold' rating assigned to Jeevan Scientific Technology Ltd indicates a balanced outlook for investors. It suggests that while the stock may not be an immediate buy, it is not advisable to sell either, given its current valuation and financial health. This rating is derived from a comprehensive assessment of four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Quality Assessment

As of 15 September 2026, the company’s quality grade is considered below average. This is primarily due to its weak long-term fundamental strength, with a compound annual growth rate (CAGR) of operating profits declining by 16.28% over the past five years. Additionally, the company’s ability to service debt remains limited, reflected in a modest EBIT to interest ratio averaging 1.37. Return on equity (ROE) also remains low at an average of 4.78%, indicating limited profitability relative to shareholders’ funds. These factors suggest that while the company operates in the healthcare services sector, it faces challenges in generating consistent, high-quality earnings growth.

Valuation Perspective

Despite the quality concerns, the valuation grade for Jeevan Scientific Technology Ltd is attractive. The stock trades at a discount relative to its peers’ historical valuations, supported by a return on capital employed (ROCE) of 3.8% and an enterprise value to capital employed ratio of 2.1. This valuation appeal is further enhanced by the company’s price-to-earnings-to-growth (PEG) ratio of 0.3, signalling that the stock is undervalued relative to its earnings growth potential. For investors, this suggests a reasonable entry point, especially given the company’s improving financial trends.

Financial Trend and Recent Performance

The financial trend for Jeevan Scientific Technology Ltd is very positive as of 15 September 2026. The company has demonstrated robust growth in net sales and profitability over recent periods. Net sales for the latest six months stand at ₹39.57 crores, reflecting a growth rate of 109.81%. Profit after tax (PAT) has surged by 148.86% to ₹2.15 crores in the same period. The company has declared positive results for three consecutive quarters, signalling improving operational performance. Additionally, cash and cash equivalents have reached a high of ₹9.51 crores, indicating a strong liquidity position. These factors contribute favourably to the company’s financial grade and support the 'Hold' rating.

Technical Analysis

From a technical standpoint, the stock exhibits a mildly bullish trend. The momentum is positive, with the stock price gaining 1.21% on the day of analysis and showing steady returns over various time frames: 6.24% over one week, 3.12% over one month, and an impressive 38.19% over six months. Year-to-date returns stand at 28.37%, while the one-year return is a remarkable 119.03%. This technical strength suggests that market sentiment is cautiously optimistic, aligning with the 'Hold' recommendation.

What This Means for Investors

For investors, the 'Hold' rating on Jeevan Scientific Technology Ltd implies a recommendation to maintain existing positions rather than initiate new purchases or sell holdings. The company’s attractive valuation and positive financial trends offer potential upside, but the below-average quality metrics and moderate technical signals counsel caution. Investors should monitor the company’s ability to sustain sales growth and improve profitability metrics, particularly its return on equity and debt servicing capacity, before considering an upgrade to a more bullish stance.

Sector and Market Context

Operating within the healthcare services sector, Jeevan Scientific Technology Ltd is classified as a microcap stock. This classification often entails higher volatility and risk, but also the possibility of significant returns if the company can capitalise on growth opportunities. The stock’s recent performance outpaces many peers, with a one-year return exceeding 119%, which is notable in the current market environment. However, investors should weigh this against the company’s fundamental challenges and the broader sector dynamics.

Summary of Key Metrics as of 15 September 2026

Jeevan Scientific Technology Ltd’s current Mojo Score stands at 56.0, reflecting a 'Hold' grade. This score improved by 10 points from the previous 46, which was associated with a 'Sell' rating before 29 May 2026. The company’s financial strength is underscored by very positive recent results, including a doubling of net sales and a near 150% increase in PAT over the last six months. However, the long-term quality concerns and modest profitability ratios temper enthusiasm.

Investor Considerations

Investors should consider the stock’s attractive valuation and recent financial momentum as reasons to maintain their holdings. The stock’s technical indicators suggest a cautiously optimistic market view, but the company’s fundamental weaknesses require ongoing scrutiny. Monitoring quarterly results and any shifts in debt servicing ability or profitability will be crucial for reassessing the stock’s outlook in the coming months.

Conclusion

In conclusion, Jeevan Scientific Technology Ltd’s 'Hold' rating by MarketsMOJO reflects a nuanced view of the company’s current position. While the stock offers value and has demonstrated strong recent growth, underlying quality issues and moderate technical signals suggest a wait-and-watch approach. Investors are advised to keep abreast of the company’s evolving fundamentals and market conditions before making significant portfolio changes.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →